Literature DB >> 30015428

Comparison of Methods Used for the Diagnosis of Epstein-Barr Virus Infections in Children.

Nilgun Kasifoglu1, Semra Oz2, Ener Cagri Dinleyici3, Tercan Us1, Ozcan Bor4, Gul Durmaz1, Yurdanur Akgun1.   

Abstract

The accurate diagnosis of Epstein-Barr virus (EBV) infections is important, as many other infectious agents or diseases can cause similar symptoms. In this study, sera of pediatric patients who were suspected to have an EBV infection, were sent to Eskisehir Osmangazi University Faculty of Medicine, Department of Clinical Microbiology, and investigated by IFA, ELISA, immunoblotting and Real-time PCR. The performances of these tests were compared with IFA. The rates of agreement between ELISA and IFA were found as 100% for seronegative, 100% for acute primary infection, 22.2% for late primary infection, 92.1% for past infection. The rates of agreement between immunoblotting and IFA were found as 80.8% for seronegative, 68.8% for acute primary infection, 55.6% for late primary infection, 86.6% for past infection. The sensitivity of immunoblotting for anti-VCA IgM was identical with ELISA, and higher for anti-VCA IgG, anti-EBNA IgG, anti-EA antibodies, while the specificity of immunoblotting for these antibodies were found to be lower. The sensitivity and specificity of Real-time PCR for detection of viremia in acute primary infection were found as 56.25% (9/16) and 97.89% (139/142), respectively. The diagnostic methods should be chosen by evaluating the demographic characteristics of patients and laboratory conditions together.

Entities:  

Keywords:  ELISA; Epstein-Barr virus; Indirect Fluorescence Assay (IFA); Real-time PCR; immunoblotting

Mesh:

Substances:

Year:  2018        PMID: 30015428     DOI: 10.5604/01.3001.0010.6287

Source DB:  PubMed          Journal:  Pol J Microbiol        ISSN: 1733-1331


  2 in total

Review 1.  Epstein-Barr Virus and Systemic Autoimmune Diseases.

Authors:  Gunnar Houen; Nicole Hartwig Trier
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

2.  A combined antibody and DNA assay for EBV infection in children.

Authors:  Yulu Yang; Yafei Zhu
Journal:  Front Pediatr       Date:  2022-08-25       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.